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Abstract
Background: Q fever in Kenya is poorly reported and its surveillance is highly neglected. Standard empiric
treatment for febrile patients admitted to hospitals is antimalarials or penicillin-based antibiotics, which have no
activity against Coxiella burnetii. This study aimed to assess the seroprevalence and the predisposing risk factors for
Q fever infection in febrile patients from a pastoralist population, and derive a model for clinical prediction of
febrile patients with acute Q fever.
Methods: Epidemiological and clinical data were obtained from 1067 patients from Northeastern Kenya and their
sera tested for IgG antibodies against Coxiella burnetii antigens by enzyme-linked-immunosorbent assay (ELISA),
indirect immunofluorescence assay (IFA) and quantitative real-time PCR (qPCR). Logit models were built for risk
factor analysis, and diagnostic prediction score generated and validated in two separate cohorts of patients.
Results: Overall 204 (19.1 %, 95 % CI: 16.8–21.6) sera were positive for IgG antibodies against phase I and/or phase
II antigens or Coxiella burnetii IS1111 by qPCR. Acute Q fever was established in 173 (16.2 %, 95 % CI: 14.1–18.7)
patients. Q fever was not suspected by the treating clinicians in any of those patients, instead working diagnosis
was fever of unknown origin or common tropical fevers. Exposure to cattle (adjusted odds ratio [aOR]: 2.09, 95 % CI:
1.73–5.98), goats (aOR: 3.74, 95 % CI: 2.52–9.40), and animal slaughter (aOR: 1.78, 95 % CI: 1.09–2.91) were significant
risk factors. Consumption of unpasteurized cattle milk (aOR: 2.49, 95 % CI: 1.48–4.21) and locally fermented milk
products (aOR: 1.66, 95 % CI: 1.19–4.37) were dietary factors associated with seropositivity. Based on regression
coefficients, we calculated a diagnostic score with a sensitivity 93.1 % and specificity 76.1 % at cut off value of 2.90:
fever >14 days (+3.6), abdominal pain (+0.8), respiratory tract infection (+1.0) and diarrhoea (−1.1).
Conclusion: Q fever is common in febrile Kenyan patients but underappreciated as a cause of community-acquired
febrile illness. The utility of Q fever score and screening patients for the risky social-economic and dietary practices
can provide a valuable tool to clinicians in identifying patients to strongly consider for detailed Q fever
investigation and follow up on admission, and making therapeutic decisions.
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Background
Q fever is an acute (on occasion chronic) zoonotic disease
of global public health importance. The disease is caused
by the obligate Gram-negative bacterium Coxiella (C.)
burnetii [1]. Domestic animals such as cattle, sheep and
goats are the main reservoirs of C. burnetii which can in-
fect a large variety of animals, humans, and arthropods
[2]. Infection in humans usually occurs by inhalation of
contaminated aerosols, consumption of contaminated
unpasteurized dairy products, direct contact with contam-
inated milk, urine, feces, or semen of infected animals,
and tick bites [3]. Clinical presentation is nonspecific and
highly variable ranging from asymptomatic infection
(60 %) or self-limiting febrile illness associated with fa-
tigue, headache, general malaise, myalgia, arthralgia, to
atypical pneumonia (rapidly progressive courses may
occur) and/or hepatitis. Less frequent manifestations in-
clude endocarditis, osteomyelitis and aseptic meningitis.
About 1–2 % of acute symptomatic cases may develop
chronic disease [4, 5]. Q fever is considered to be an occu-
pational disease of people who have intimate contact with
animals or their products such as veterinarians, farmers,
abattoir workers, and laboratory workers [4, 6].
Acute Q fever in humans is confirmed when a pa-
tient present with clinically compatible symptoms and
detection of the C. burnetii by at least one of the fol-
lowing diagnostic tests; cultivation, detection of C.
burnetii DNA from any clinical specimens (usually
blood or respiratory secretions), detection of C. burne-
tii in a clinical specimen by immunohistochemistry
(IHC), seroconversion or a fourfold increase from
non-negative titer sera [7]. In the absence of positive
culture, IHC or PCR results, and when acute and con-
valescent serum samples cannot be obtained, elevated
phase II IgG antibodies level by ELISA or positive in-
direct immunofluorescence assay (IFA) (IgG phase II
≥1:128) in a patient who has been ill longer than
1 week is laboratory supportive of acute Q fever infec-
tion while IgG phase I titer ≥1:800 is seen in chronic
patients [2, 7–9].
Q fever is a notifiable disease in many developed
countries, but it is poorly reported in sub-Saharan
Africa and its surveillance is highly neglected [10].
Available reports from previous studies show remark-
able high seroprevalence in the African countries with
intensive livestock production systems [11–13]. Pas-
toralist communities are particularly at high risk of
pathogen exposure because of their itinerant lifestyle
and highly conserved traditions that make them more
likely to consume unboiled milk products and raw
meat from infected animals. They are also less likely
to protect themselves when handling animal birth
products and vaginal discharges after abortion or full-
term parturition [14, 15]. Despite these, few studies
have investigated in detail the risk factors or the rea-
sons for variation of prevalence in the diverse agro-
ecological African settings [10]. This lack of attention
is mainly caused by lack of data and the perceived low
clinical relevance of Q fever in relation to other en-
demic fevers [16, 17].
In Kenya, Q fever in humans was first reported in hos-
pitalized patients in 1950s [18–20]. A serosurvey by
Vanek and Thimm, (1976) detected seroprevalences ran-
ging from 10 to 35.8 % in patients from five provinces of
Kenya [21]. An outbreak of Q fever involving safari trav-
elers in a game park was described in 2000 in which 4
(8 %) of fifty travelers contracted the disease [22]. A re-
cent study in a rural hospital in western Kenya demon-
strated IgG antibodies to C. burnetii antigens in 30.9 %
of acute febrile illness (AFI) patients. In addition, acute
Q fever was detected in 3 % of patients diagnosed with
acute lower respiratory infections (ALRI) in the same
hospital [17]. Among domestic animals in Kenya, preva-
lence of Coxiella antibodies was reported ranging from
7.4 to 51.1 % in cattle, 6.7 to 20 % in sheep, 20 to 40 %
in goats, and 20 to 46 % in camels [17, 20, 21, 23].
There is emerging evidence of C. burnetii as a cause
of non-malaria febrile illness and community acquired
pneumonia in many African countries including Kenya
[16, 17, 24–27]. Many etiologies of febrile illnesses are
difficult to distinguish from one another clinically and
reliable laboratory diagnostic facilities are often limited
in developing countries, thus clinical management of
such illness is often driven by syndrome-based local
guidelines employing empiric treatment [28]. This
makes timely and accurate diagnosis or management of
the neglected diseases such Q fever an important chal-
lenge to clinicians [29]. A systematically collected data
on Q fever burden estimates and risk factor analysis is
needed to support development of targeted interven-
tional control policies. In addition, a simple clinical
algorithm with high diagnostic sensitivity and specifi-
city remains an important tool for timely detection, and
prevention of morbidity associated with Q fever in
regions where laboratory facilities are lacking.
This study aimed to estimate the seroprevalence of Q
fever in patients with febrile illness seeking treatment at
two hospitals in the Northeastern province of Kenya and
investigate the risk factors for seropositivity. We also eval-
uated the usefulness of clinical signs and symptoms in
predicting Q fever outcome. We hypothesized that a clin-
ical prediction score system with high diagnostic accuracy
would be of benefit to clinicians who work in resource
scarce settings in making decisions on febrile patients to
strongly consider for Q fever investigation during initial
diagnosis, and when making empirical therapeutic deci-
sions. This hypothesis was tested using derivation and val-
idation cohorts.
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Methods
Study area
The study was conducted at Garissa Provincial
Hospital (GPH) and Wajir District Hospital (WDH) of
Northeastern province of Kenya (Fig. 1). GPH has 224
beds and serves an estimated population of 623,060
individuals, whereas WDH has 120 beds serving about
661,941individuals. These health facilities are also the
main referral hospitals of the Garissa and Wajir coun-
ties respectively. The province has an arid and semi-
arid lands (ASAL) climate and is almost exclusively
inhabited by the Somali ethnic groups who are pre-
dominantly nomadic pastoralists. Livestock keeping is
the main economic activity in the region. The com-
mon diet for the communities in the province is meat
and milk [15, 30].
Drinking of raw milk is common in this population
due to deep-rooted cultural traditions. It is believed
that boiling milk reduces the nutritional value of milk.
Milk is also mixed from several animals in common
containers. From this milk, fermented products (local
name ‘susac’) are prepared. Susac would then be sold at
the nearest open market places and nomadic camp sites
[15, 31]. This province was selected because public
health support and disease surveillance has been ex-
tremely limited and outbreaks of re-emerging diseases
have been reported in the province before [32–34].
Study participants and procedures
The hospital-based study was conducted between June
2014 and January 2015. Acute febrile patients presenting
to the outpatient departments of the two hospitals were
systematically assessed for enrollment. The inclusion cri-
teria were: a clinical history of acute febrile illness (AFI)
characterized by fever (higher than or equal to 38 °C)
and at least one of the following clinical symptoms:
headache, chills, myalgia, arthralgia, general body mal-
aise, and acute lower respiratory illness (ALRI). ALRI
was defined as new onset of cough, difficulties when
breathing or chest pain and fever [17]. A study clinician
then collected demographic information, obtained clin-
ical history and performed physical examination of the
enrolled participants. The clinical diagnosis made by the
attending hospital clinician was also recorded. Exclusion
criteria were: patients younger than 18 years not accom-
panied by a guardian or parents, patients who had an
already established diagnosis and those who were se-
verely sick and were considered not able to provide in-
formed consent. Patients who declined to participate
were also excluded.
Sample and data collection
Demographic information and data on putative social-
economic and dietary characteristics of the patients
were collected using pre-tested questionnaires. Risk
factors were assessed in form of a mix of closed- and
open-ended questions including the following data: (a)
living in a livestock keeping household/nomad camp
or involvement in animal husbandry activities for at
least 2 days a week (hereafter referred to as ‘regular
contact with animals’), (b) animal species involved,
and (c) the type of contact with animals or their prod-
ucts i.e. help in animal parturition, contact with
aborted materials, grazing animals, livestock trade,
handling raw milk, and animal slaughter. Participants
were also asked if they shared their house with ani-
mals and if they were involved in manure preparation.
The food variables assessed were: (i) consumption of
raw milk, (ii) locally fermented milk products (susac),
(iii) drinking of animal blood and (iv) consumption of
uncooked meat.
Following cleansing of the skin with isopropyl alcohol
and povidone iodine, five milliliters of venous blood
were collected aseptically into empty 10 ml serum BD
vacutainer tubes® (Becton, Dickson and Company, USA).
The blood samples were stored at room temperature for
45 min to allow blood clotting. The samples were then
centrifuged at 2500 rpm for 5 min and serum was sepa-
rated. Sera were aliquoted into cryo-vials before shipping
to Friedrich-Loeffler-Institut (FLI) for Q fever laboratory
analysis.
GPH
WDH
Fig. 1 Map of Kenya showing Northeastern Province of Kenya
(shaded area). The location of Garissa Provincial Hospital (GPH) and
Wajir District Hospital (WDH) are marked with black dots
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Serological analysis
Sera were analyzed for IgG antibodies against phase I
and phase II antigens using serion ELISA classic test kits
(Virion\Serion, Würzburg, Germany) and evaluated ac-
cording to the manufacturers’ recommendations. For
phase I, samples with an optical density (OD) >10 %
above OD of the cut-off sera were scored as positive,
those with ODs >10 % below OD of the cut-off sere
were considered as negative, in between samples were
denoted as borderline. For phase II, the cut off value
was calculated on the basis of the standard curve cor-
rected by the mean of the extinction of the standard
serum according to the manufacturers’ instructions. A
result of <20 U/ml was regarded as negative, 20–30 U/
ml borderline, and >30 U/ml as positive.
The seropositive samples and those with inconclusive
results were confirmed with a commercial IFA for detec-
tion of IgG antibodies against C. burnetii phase I and
phase II (Fuller Laboratories, USA). The assay titers
were started at 1:16 and results interpreted according to
the manufacturers’ instructions. Samples with C. burnetii
phase II antibodies titers of >1:128 were scored as acute
Q fever positive, while those with phase I antibodies ti-
ters of ≥1:800 were regarded as positive for chronic Q
fever. The samples that were found to be equivocal in
the repeat tests were re-tested at the Q fever consulting
laboratory Baden-Wurttemberg, State Health Office,
Germany.
DNA extraction from samples
DNA isolation was done using the High Pure PCR Tem-
plate preparation commercial Kit™ (Roche Diagnostics,
Germany) according to the manufacturer’s instructions.
Purity and concentration of DNA was tested using a
Nano Drop ND-1000 UV-vis spectrophotometer (Nano
Drop Technologies, Wilmington, USA), and DNA sam-
ples were stored at −20 °C until analyzed.
Quantitative Real-time PCR assay (qPCR)
Detection of C. burnetii DNA was performed with a Taq-
Man based qPCR assay targeting the repetitive element
IS1111 as described by Klee et al. [35] using a Stratagene
Mx3000P v 4.01Thermocycler (Agilent Technologies, Santa
Clara, USA). No template control (NTC) and tenfold serial
dilution of cloned IS1111 gene plasmid fragments ranging
from 1 × 100 to 1 × 105 plasmid copy numbers were used
for Coxiella DNA quantification and sensitivity control of
the assay. Cycling conditions were as follows: one pretreat-
ment cycle at 50 °C for 2 min, initial denaturation at 95 °C
for 10 min, followed by 50 cycles at 95 °C for denaturation
for 15 s, and 30 s for annealing and elongation at 60 °C. No
internal amplification control (IAC) was used in the
procedure to ensure high sensitivity. Cycle threshold (Ct)
values ≤ 36 cycles were interpreted as positive. The
threshold was calculated automatically by the instruments’
software based on six 10 fold serial dilutions of C. burnetii
DNA in negative human sera assessed simultaneously in a
single run.
Case definitions
Acute Q fever case was defined as a patient with com-
patible clinical evidence criteria and laboratory support-
ive results for acute Q fever illness, reflected by elevated
IgG phase I and phase II antibodies by ELISA and con-
firmed by C. burnetii phase II antibodies titers of >1:128
by IFA assay or detection of Coxiella DNA by qPCR.
Chronic case was defined as those with elevated IgG
phase I antibodies by ELISA and phase I antibodies titers
of ≥1:800 by IFA assay. The case definition criteria was
based on a combination of recommendations of the kits
manufacturer and as proposed by EFSA [2], CDC [7],
and previous authors [8, 9, 36]. In all cases, Salmonella
spp, Brucella spp, and Plasmodium spp were excluded.
For statistical analysis, seropositivity was defined as any
participant who met the criteria for acute or chronic Q
fever.
Data management and statistical analysis
Questionnaire results and serological data were entered
into Microsoft excel 2010 spreadsheet and exported to
SPSS Statistics software® (Armonk, IBM Corp, USA.
v.20) and verified against the paper questionnaires and
laboratory sheets for consistency and completeness. The
Pearson’s χ2test or Fisher’s exact test was used to deter-
mine differences in Q fever seroprevalence among
demographic groups. Statistical significance was set at P
value < 0.05.
Multivariate logistic regression models were built to
assess clinical features, and plausible socio-demographic,
economic and dietary characteristics of the patients as-
sociated with Q fever seropositivity using stepwise back-
ward analysis procedure. Briefly, univariate analysis was
performed for all covariates in each model and pair-wise
collinearity assessed using Spearman rank correlation. A
pair of the variables was considered collinear if the cor-
relation coefficient was equal or greater than 0.8. Multi
collinearity was then assessed for all potential variables
by estimating the variance inflation factor (cut-off 5) and
tolerance (cut-off 0.2) levels using collinearity diagnos-
tics function (IBM Corp, USA. v.20). The variables were
then droped or aggregated as appropriate.
The candidate covariates with p < 0.2 using (Wald test)
were fitted into the multivariable model and those exhi-
biting the highest p-values (Wald test) were removed
one at a time from the model until all the retained vari-
ables had p < 0.05. The eliminated variables were re-
screened for confounding and were retained if their
inclusion caused 20 % or more change to the coefficients
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of one or more of the retained variables. Age was con-
sidered to be a biologically important variable and thus
was kept in the final model. Finally, both the clinical and
putative socio-economic and dietary characteristics from
the two sub models were combined in a multivariate
analysis to identify the independent risk determinants
for Q fever seropositivity. The Hosmer-Lemeshow test
was used for assessing final models’ goodness of fit
(GOF). The area under the ROC curve was also gener-
ated to assess the predictive ability of the final best
model.
To derive and evaluate a predictive clinical model
best-fit for identification of a subgroup of patients with
high likelihood of acute Q fever, the patients were ran-
domly assigned to derivation set and validation set using
random number generated using the SPSS random num-
ber generator function (IBM Corp, USA. v.20). The der-
ivation set used to fit the model composed of 65 % of
the sample (n = 707) while the validation set used to val-
idate the model was made up of 35 % of the sample (n =
360) [37]. A clinical prediction score “Q fever score” was
then generated using the β coefficients of the final best
fit model and the discriminatory power of this score
evaluated by the area under the receiver operating char-
acteristics (ROC) curve at the 95 % confidence interval
(CI). Then a cut-off value to estimate the diagnostic sen-
sitivity and specificity in the validation set was selected
[38].
Results
Study population
A total of 1067 participants (WDH: 536 and GPH: 531)
were enrolled in the study. The study participants were
fairly distributed between male and female (45.6 vs
54.4 %). Nine hundred thirty-six participants were adults
(>18 years), of which 963 (90.3 %) were of Somali ethni-
city. Whereas most of the patients did not have any for-
mal education (n = 661; 61.9 %), nearly half (n = 448;
42.0 %) had knowledge about zoonosis but only 5
(0.5 %) reported prior knowledge of Q fever. Eight hun-
dred eighty-five patients reported regular contact with at
least one animal species. Out of these, the Somali ethnic
group reported more contacts (n = 818; 84.9 %) than
other ethnic groups (n = 67; 64.4 %). Demographic char-
acteristics of patients as well as the number positive for
acute Q fever are shown in Table 1.
Majority (n = 689; 64.6 %) of the participants reported
regular contact with goats whilst less than half had con-
tact with cattle (n = 465; 43.6 %) and sheep (n = 392;
36.7 %). Only 112 (10.5 %) reported regular exposure to
camels. The type of exposure included; animal grazing
(n = 717; 67.2 %), handling of raw milk (n = 597; 56 %),
and animal slaughter (n = 382; 35.8 %). One hundred
fifty-eight (14.8 %) patients reported to help in animal
parturition and 44 (4.1 %) reported exposure to aborted
or after birth animal materials. Consumption of raw milk
was common among the participants. Almost all partici-
pants of Somali origin (n = 907; 94.2 %) reported con-
sumption of raw milk. Less than a half (n = 38; 36.5 %)
of other ethnic groups reported to do so. Consumption
of raw camel milk (n = 943; 88.4 %), raw cattle milk (n =
331; 31 %), and locally fermented milk product (n = 409;
38.3 %) were commonly reported, whereas consumption
of raw goat milk was less common (n = 184; 17.2 %).
Table 2 summarizes the frequency of animal contacts
and dietary exposure of the study participants and num-
bers positive for acute Q fever.
Seroprevalence
A total of 204 (19.1 %, 95 % CI: 16.8–21.6) participants
were found to be positive for Q fever based on a parallel
interpretation of the three tests applied. Of these, 181
(17.0 %, 95%CI: 14.8–19.4) had anti-Coxiella phase II IgG
antibodies while 175 (16.4 %, 95%CI: 14.2–18.8) had IgG
antibodies against phase I antigens. One hundred ninety-
four (18.2 %, 95 % CI: 15.9–20.7 %) patients were positive
for IgG antibodies against either phase II or phase I anti-
gens, whilst 162 (15.2 %, 95 % CI: 13.2–17.5) patients were
found to be positive for anti-Coxiella IgG antibodies
against both phase I and phase II antigens (Table 1). Thir-
teen and eighteen participants tested positive for only IgG
phase I and IgG phase II antigens, respectively. One pa-
tient remained positive for IgG phase II and borderline for
phase I in the repeat tests. Based on the study case defin-
ition criteria, acute Q fever was established in a total of
163 (15.3 %, 95 % CI: 13.2–17.6) patients whereas none of
the patients had IgG antibody titers against phase I sup-
portive of chronic Q fever infection.
Molecular detection of Q fever
Quantitative real-time PCR (qPCR) demonstrated C.
burnetii specific DNA in 2.2 % (10/448) of the examined
patients, of which all were serologically negative for Q
fever. The tested sera were from patients whose onset of
the illness was ≤ 2 weeks and had no antibiotic therapy.
The PCR of whole blood or serum is mainly positive
within the first two weeks following symptom onset, and
becomes negative as the antibody response develops. De-
tectable seroconversion typically occurs one to three
weeks after symptoms appear [39].
Q fever was not clinically suspected by the treating clini-
cians in any of 173 (16.2 %) positive patients, instead the
working diagnosis were mainly presumptive typhoid fever
(45.1 %), malaria (6.9 %), pneumonia oracute respiratory in-
fections (37.6 %) and others or fever of unknown origin
(FUO) (10.4 %). There was no significant difference in infec-
tion found between males and females (P= 0.736). Higher
seroprevalence (16.7 %, 95 % CI: 14.4–19.3) was found
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Table 1 Demographic characteristics of study participants and numbers positive for acute Q fever among the febrile patients, Northeastern Kenya
Variable Total Number (%) IgG PII positive (N = 1067) IgG PI positive (N = 1067) IgG PI/PII positive (N = 1067) qPCR positive (N = 448) Q fever positivea (%) (N = 1067) 95 % (CI) P-value
Age Group (years)
0–18 131 (12.3) 16 15 18 0 17 (13.0) 8.0–20.2 0.283
18+ 936 (87.7) 165 160 176 10 156 (16.7) 14.4–19.3
Total 1067 (100 %) 181 (17.0 %) 175 (16.4 %) 194 (18.2 %) 10 (2.2 %) 173 (16.2 %) 14.1–18.7 -
Gender
Female 580 (54.4) 102 98 109 4 96 (16.6) 13.7–22.9 0.736
Male 487 (45.6) 79 77 85 6 77 (15.8) 12.6–19.4
Occupation
Herder 678 (63.5) 140 138 150 7 134 (19.8) 16.9–23.1 <0.001
Civil servant 142 (13.3) 10 8 10 0 9 (6.3) 3.1–12.2
General merchandise 74 (6.9) 8 7 9 0 6 (8.1) 3.3–17.4
Livestock trader 59 (5.5) 15 14 16 2 15 (25.4) 15.4–38.7
Student 62 (5.8) 4 5 5 0 5 (8.1) 3.0–18.5
Others 52 (4.9) 4 3 4 1 4 (7.7) 2.5–19.4
Education Level
None 661 (61.9) 129 132 141 7 130 (19.7) 16.8–22.9 <0.001
Post-secondary 114 (10.7) 12 10 12 0 10 (8.8) 4.5–15.9
Primary 206 (19.3) 36 29 37 2 30 (14.6) 10.2–20.3
Secondary 86 (8.1) 4 4 4 1 3 (3.5) 1.1–9.8
Residence county
Garissa 531 (49.7) 86 84 93 6 83 (15.6) 12.7–19.1 0.607
Wajir 536 (50.3) 95 91 101 4 90 (16.8) 13.8–20.3
Ethnic groups
Somali 963 (90.3) 173 167 188 8 165 (17.1) 14.8–19.7 0.004
Others 104 (9.7) 8 8 6 2 8 (7.7) 3.6–15.4
Zoonosis knowledge
Yes 448 (42.0) 62 61 67 2 58 (12.9) 10.0–16.5
No 619 (58.0) 119 114 127 8 115 (18.6) 15.6–21.9 0.012
Q Fever knowledge
Yes 5 (0.5) 0 0 0 0 0 - -
No 1062 (99.5) 181 175 194 10 173 (16.2) 14.1–18.7
CI confidence interval, IgG PII/I IgG antibodies against phase II/I Coxiella antigens
aPatients meeting case definition for acute Q fever by serology or Coxiella DNA detection by qPCR
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in adults (>18 years) when compared to those aged
below (13.0 %, 95 % CI: 8.0–20.2), but the difference
was not statistically significant (P = 0.283). Somalis were
more often seropositive when compared with other eth-
nic groups (Somali, 17.1 %, 95%CI: 14.8–19.7 and Non-
Somali, 7.7 %, 95%CI: 3.6–15.4, P = 0.004, Table 1).
Among 885 participants who reported regular contact
with animals, 160 (18.1 %, 95%CI: 15.7–20.8) tested
positive for Q fever whereas only 13 (7.1 %, 95 %: CI:
4.10–12.2) who reported no contact with animals were
Table 2 Frequency of animal contacts and dietary exposure self-reported by febrile patients in Northeastern Kenya
Characteristic Variable Total No. patients (%) Positive for Q fevera (%) Crude OR (95%CI) P value
Contact with goat No 378 52 (13.70) Ref -
Yes 689 121 (17.6) 4.82 (2.89–8.26) 0.003
Contact with dog Yes 22 1 (4.5) Ref -
No 1045 172 (16.5) 0.24 (0.03–1.81) 0.267
Contact with sheep No 675 104 (15.4) Ref -
Yes 392 69 (17.6) 1.17 (0.84–1.64) 0.349
Contact with cattle No 602 63 (10.5) Ref -
Yes 465 110 (23.7) 2.65 (1.89–3.72) <0.001
Contact with camel Yes 112 13 (11.8) Ref -
No 955 160 (16.7) 0.67 (0.37–1.22) 0.279
Frequent slaughtering of animals No 685 68 (9.90) Ref -
Yes 382 105 (27.5) 3.44 (2.46–6.67) <0.001
Frequent handling of raw milk No 470 61 (13.0) Ref -
Yes 597 112 (18.8) 1.55 (1.10–2.18) 0.011
Contact with birth productsb No 865 148 (17.1) Ref -
Yes 202 25 (12.4) 1.43 (0.94–2.19) 0.089
Share house with animals Yes 98 20 (20.4) Ref -
No 969 153 (15.8) 0.37 (0.08–1.31) 0.239
Frequent contact with wildlife Yes 2 0 (0) - -
No 1065 173 (16.2)
Frequently prepare manure Yes 50 11 (22.0) Ref -
No 1017 162 (15.9) 1.49 (0.44–1.97) 0.258
Frequently graze animals No 350 37 (10.6) Ref -
Yes 717 136 (19.0) 1.98 (1.34–2.92) <0.001
Frequent consumption of raw meat Yes 57 14 (24.6) Ref -
No 1010 159 (15.7) 0.74 (0.13–3.26) 0.382
Frequent consumption of raw cattle milk No 736 57 (7.7) Ref -
Yes 331 116 (35.0) 6.43 (4.52–9.14) <0.001
Frequent consumption of raw goat milk No 883 130 (14.7) Ref -
Yes 184 43 (23.4) 1.77 (1.20–2.61) 0.004
Frequent consumption of raw camel milk No 124 17 (13.7) Ref -
Yes 943 156 (16.5) 1.24 (0.73–2.14) 0.422
Frequent consumption of locally fermented milk No 658 60 (9.1) Ref -
Yes 409 113 (27.6) 3.81 (2.7–5.36) <0.001
Frequent consumption of animal blood Yes 45 3 (6.7) Ref -
No 1022 170 (16.6) 0.36 (0.11–1.17) 0.809
Ref referent category, OR odd ratio, CI confidence interval
aPatients meeting case definition for acute Q fever by serology or Coxiella DNA detection by qPCR
bProportion of patients with recent exposure to aborted materials or help during animal birth
Bold font implies statistically significant results at (P < 0.20) that were retained as possible factors and subsequently fitted in the multivariate analysis
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positive (P < 0.001). Most cases of Q fever occurred in
full time herders 134 (19.8 %, 95%CI: 16.9–23.1) and
livestock trader 15 (25.4 %, 95%CI: 15.4–38.7) when
compared to government workers, general merchandise
businesses and other occupations (P < 0.001). Patients
from Wajir county were slightly more seropositive 90
(16.8 %, 95%CI: 13.8–20.3) than those from Garissa
county 83 (15.6 %, 95 %: CI: 12.7–19.1) but the differ-
ence was not statistically significant (P = 0.607). Finally,
patients without knowledge of zoonosis 115 (18.6 %,
95%CI: 15.6–21.9, P = 0.012) and those without any
form of education 130 (19.7 %, 16.8–22.9, P < 0.001)
were more often seropositive (Table 1).
Clinical predictors of acute Q fever diagnosis and ‘Q
fever’ score
There were 392 (55.4 %) females in the 707 derivation co-
hort and 188 (52.2 %) females in the 360 validation group.
The mean age was 33.6 years (Standard Deviation [SD],
12.2 years) for derivation group and 38.3 years (SD
17.7 years) for the validation group. The mean interval
from the onset of fever symptoms until hospital presenta-
tion was 14.5 days (SD 10.6 days)/median 8 days for cases
in the derivation cohort and 11.9 days (13.2 days)/median
7 days for the validation group. The symptoms and clinical
features of the patients are summarized in Table 3. Al-
though the symptoms reported from patients were often
combined, Table 3 presents the number of cases in which
a particular symptom was reported. Acute Q fever was
established in 116 (16.4 %) patients in the derivation
group while 57 (15.8 %) patients tested positive in the val-
idation group. Differential diagnosis for selected febrile
etiologies was undertaken among the patients, including
those classified as with FUO. The tests were selected
based on the patients’ clinical syndrome, the most preva-
lent infections reported to occur in the region and the na-
ture of available laboratory support. These included
screening the patients for typhoid fever, malaria, and bru-
cellosis (data not included here). Supportive radiological
investigations, hematology and liver enzyme tests were
scarcely available and are not presented here.
Univariate analysis of the signs and symptoms revealed
that general body malaise and fatigue, ALRI, constipation,
abdominal pain, diarrhoea, and fever onset (>2 weeks) were
possibly associated with Q fever seropositivity (P < 0.20;
Table 3).
In the final clinical logit model, adjusted for possible con-
founding variables, ALRI (adjusted Odds ration [aOR]:
Table 3 Symptoms and clinical features of the febrile patients, Northeastern Kenya
Variable Total No. (n = 707) Positive for Q fevera (%) (n = 116) Crude OR (95%CI) P- value
Headache 630 104 (16.5) 1.07 (0.56–2.05) 0.836
Chills 388 64 (16.5) 1.04 (0.68–1.51) 0. 945
Arthralgia/Myalgia 541 87 (16.1) 0.91 (0.57–1.44) 0.673
Malaise/Fatigue 493 87 (17.6) 1.37 (0.87–2. 15) 0.178
Anorexia 404 62 (15.3) 0.84 (0.56–1.25) 0. 380
ALRI 200 61 (30.5) 3.61 (2.39–5.44) <0.001
Constipation 129 28 (21.7) 1.54 (0.96–2.48) 0.074
Night Sweats 94 12 (12.8) 0.71 (0.38–1.36) 0.308
Diarrhoea 73 8 (11.0) 0.60 (0.28–1.29) 0.081
Weight loss 62 11 (17.7) 1.11 (0.56–2.20) 0.765
Confusion 15 1 (6.6 %) 0.31 (0.01–7.09) 0.801
Rash 28 6 (21.4) 1.41 (0.56–3.56) 0.466
Vomiting 13 1 (7.7) 0.42 (0.05–3.23) 0.401
Abdominal pain 173 37 (21.4) 1.57 (1.01–2.42) 0.043
Palpable spleen 91 18 (19.8) 1.31 (0.56–8.69) 0.640
Palpable liver 38 5 (13.1) 0.78 (0.34–1.47) 0.486
Fever onset (>14 days) 253 108 (42.7) 41.52 (19.78–87.22) <0.001
Age (>18 years) 618 106 (17.2) 1.64 (0.82–3.26) 0.162
Mean (SD)
Age (years) 707 33.6 ± 12.2
Fever onset (days) 707 14.5 ± 10.6
ALRI acute lower respiratory infection, OR odds ratio, CI 95 % confidence interval, SD standard deviation
aPatients meeting case definition for acute Q fever by serology or Coxiella DNA detection by qPCR
Bolded variables were considered significant (P < 0.20) and fitted into multivariate logistic regression model
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2.68, 95%CI: 1.65–4.36), fever onset (>2 weeks) (aOR:
37.59, 95%CI: 17.83–79.27) and abdominal pain (aOR 2.19,
95%CI: 1.02–4.72) were positive predictors of Q fever infec-
tion. The analysis revealed that diarrhoea (aOR: 0.34,
95%CI: 0.12–0.96) had predictive value for a negative acute
Q fever outcome (P < 0.05; Table 4). Using the four vari-
ables, predictive score was generated and the scale simpli-
fied by assigning values to the nearest one decimal scale
(fever onset >2 weeks: +3.6, ALRI: +1.0, abdominal pain: +
0.8 and diarrhoea: −1.1, Table 4). The discriminatory power
of the fitted ROC curve area was 0.883 (95%CI: 0.851–
0.915, P < 0.001, Fig. 2a). An optimal cut-off value of 2.90
(sensitivity 93.1 % and specificity 76.1 %) was selected
(Fig. 2b). Only a history of fever (>14 days) singly was a
good predictor of positive diagnosis (sensitivity 90.5 % and
specificity 76.8 %). The prediction remained strong, if diar-
rhoea was absent or when at least one of positive predictors
was also present. However, none of other clinical predictors
(ALRI or abdominal pains) alone or in combination had
significant predictive value for positive acute Q fever out-
come. Thus, pre-admission fever onset (>14 days) in associ-
ation with ALRI and abdominal pain and no diarrhoea was
the best predictor algorithm for acute Q fever outcome.
The prediction rule, reliably identified febrile patients with
a score >2.90 as 12.7 times more likely to have a positive
acute Q fever test outcome (OR= 12.7; 95 % CI: 4.89–
32.72) than the patients with a Q fever score up to 2.90.
Risk factor analysis for acute Q fever
Univariate analyses of demographic, social-economic and
dietary characteristics showed no significant associations
with seropositivity between gender, county of residence of
the patient or across different age strata, and occupations
except herders (OR; 2.96, 95 % CI: 1.15–8.34) and livestock
traders (OR; 4.09, 95 % CI: 1.26–13.27) who had signifi-
cantly higher odds for seropositivity. Having secondary edu-
cation or above (OR; 0.39, 95 % CI: 0.17–0.81) and
knowledge about zoonosis (OR; 0.78 CI: 0.36–0.99) were
associated with decreased risk of Q fever seropositivity.
Odds of Q fever seropositivity were significantly higher for
patients of Somali ethnicity (OR; 1.92, 95 % CI: 1.29–3.76).
Regular contact with cattle (OR; 2.65, 95 % CI: 1.89–
3.72) or goats (OR; 4.82, 95 % CI: 2.89–8.26) were inde-
pendently associated with Q fever seropositivity. The risk
for Coxiella infection was higher for those who reported
the following: contact with aborted materials or assist in
animal births (OR; 1.43, 95 % CI: 0.94–2.19), handling raw
milk (OR; 1.55, 95 % CI: 1.10–2.18), grazing animals (OR;
1.98, 95 % CI: 1.34–2.92), and slaughtering of animals
(OR; 3.44, 95 % CI: 2.46–6.67). Q fever seropositivity was
significantly associated with consumption of raw cattle
milk (OR; 6.43, 95 % CI: 4.52–9.14), raw goat milk (OR;
1.77, 95 % CI: 1.20–2.61) and locally fermented milk prod-
ucts (susac) (OR; 3.81, 95 % CI: 2.73–5.36) (Table 2).
In the final combined multivariate analyses, significant
association persisted for pre-admission fever (>14 days)
(aOR; 36.35, 95 % CI: 19.84–69.49) and ALRI (aOR;
2.41, 95 % CI: 1.53–6.36), while abdominal pain (aOR;
1.95, 95 % CI: 1.28–3.58) association with seroposivity
was strengthened.
Regular contact with cattle (aOR: 2.09, 95 % CI: 1.73–
5.98), or goats (aOR: 3.74, 95 % CI: 2.52–9.40) and fre-
quent slaughter of animals (aOR: 1.78, 95 % CI: 1.09–
2.91) remained with significantly higher odds of sero-
positivity. The dietary exposures significantly associated
with seropositivity in the final combined model included:
consumption of raw cattle milk (aOR: 2.49, 95%CI:
1.48–4.21) and locally fermented milk products (aOR:
1.66, 95%CI: 1.19–4.37).
The odds of Q fever were lower for patients who pre-
sented with diarrhoea (aOR; 0.63, 95 % CI: 0.38–1.00) and
for those with secondary education or above at the time of
hospital visit (aOR; 0.71, 95 % CI: 0.24–0.96) (Table 5).
Discussion
This cross-sectional study from a pastoralist community
in Kenya found an unexpectedly high prevalence (16.2 %)
Table 4 Result of multivariate analysis showing significant
clinical predictors for acute Q fever and calculation of Q fever
score
Variable Crude OR
(95%CI)
aOR (95%CI) β
Coefficient
P-
value
ALRI
No Ref Ref -
Yes 3.61
(2.39–5.44)
2.68
(1.65-4.36)
0.986 <0.001
Abdominal pain
No Ref Ref -
Yes 1.57
(1.01–2.42)
2.19
(1.02–4.72)
0.788 0.004
Diarrhoea
No Ref Ref -
Yes 0.60
(0.28–1.29)
0.34
(0.12–0.96)
−1.075 0.042
Fever onset
(>14 days)
No Ref Ref -
Yes 41.52
(19.78–87.22)
37.59
(17.83–79.27)
3.627 <0.001
H-L test 0.567
ROC (AUC) 0.883 (0.851–0.915) <0.001
Q fever score Q fever score (rounded) = 1.0x(ALRI) +
3.6x(Symptoms onset (>14 days) + 0.8x (Abdominal
pains) -1.1x(Diarrhoea).
ALRI acute lower respiratory infection, Ref referent category, aOR adjusted
odds ratio, CI 95 % confidence interval, H-L test Hosmer-Lemeshow goodness-
of-fit test, ROC receiver operating characteristics, AUC area under the curve
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of acute Q fever in febrile patients who were not sus-
pected of Q fever infection during hospital diagnosis. In-
stead these patients were mainly suspected for the
common tropical fevers or fever of unknown origin. Previ-
ous studies in Kenya have found that a considerable pro-
portion of febrile patients still continue to be treated for
presumptive malaria and blood stream infections using
antimalarials and penicillin based antibiotics, respectively
[40–42]. However, these treatments have no activity
against C. burnetii. Though not directly assessed in the
present study, our findings strongly suggest that patients
with Q fever were likely to leave hospital without the spe-
cific treatment for Q fever. These results taken together
with previous studies elsewhere in Africa [27, 40, 41, 43,
44], provide further evidence that in absence of clear
guidelines for the management of febrile illness and in-
corporation of reliable diagnostic tests in the hospitals to
enable accurate fever diagnosis, clinicians continues to en-
counter missed opportunities to accurately detect and
treat other causes of fever. The patients thus don’t benefit
from appropriate antibiotic therapy.
The prevalence of Q fever in this study compare to
that reported in similar studies in Burkina Faso (13.1 %)
[45] and Egypt (12 %) [46], but the seroprevalence was
considerably higher than that reported in Tunisia (8 %)
[27], Mali (5 %) [26] and Tanzania (5 %) [43]. Similarly,
our results do not correspond to the findings of studies
conducted in Croatia (27.5 %) [47], Iran (35.2 %) [48]
and Turkey (36 %) [49], respectively. However, it is diffi-
cult to compare findings of studies done in different
countries because of the different sampling criteria, se-
lected study population, and the different laboratory
tests and cut-offs used that may affect the outcomes.
We found no significant difference in infection among
individual age groups or sex. This is dissimilar to previ-
ous studies in different (high-income) settings [1, 50, 36]
which suggest that older persons (25–60 years) and men
are at a greater risk of infection due to cumulative risk
of exposure and men dominance in risky occupations. In
contrast, a study by Muga et al. [15] described nomadic
pastoralism in Kenya as highly labor-intensive and work
is shared out almost entirely by all household members
(including children above four years). This implies that
the entire population may be at risk of exposure to in-
fected animals or materials very early in life.
In our study, a new prediction score (Q fever score) reli-
ably differentiated acute Q fever infection in febrile pa-
tients with undifferentiated illness. With a cut off value of
2.90 (sensitivity 93.1 % and specificity 76.1 %), the best
diagnostic algorithm; history of fever (>14 days) singly
without diarrhoea, or in associated with ALRI and/or ab-
dominal pains had the best predictive value for positive
acute Q fever outcome. On the contrary, ALRI or abdom-
inal pains present alone or in combination did not meet
the threshold predictive of infection and especially when
associated with diarrhoea. To our knowledge, this is the
Fig. 2 a Receiver Operating Characteristics (ROC) and Area Under the Curve (AUC) for assessing the discriminatory capacity of the Q fever score.
b Cut-off values for the ROC curve
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Table 5 Results of final combined logistic regression analysis showing risk factors found associated with Q fever seropositivity in
febrile patients, northeastern Kenya
Risk factor Variable Crude OR P- value aOR(95%CI) P- value
Age Groups (years) <19 Ref - Ref -
>19–29 0.70 (0.37–1.35) 0.282 1.16 (0.63–3.92) 0.178
30–39 1.52 (0.86–2.65) 0.145 1.86 (0.55–8.26) 0.433
40–49 1.73 (0.97–3.10) 0.063 2.03 (0.87–4.38) 0.609
>50 1.28 (0.66–2.48) 0.458 1.21 (0.51–2.97) 0.124
Gender Female Ref - - -
Male 0.95 (0.68–1.31) 0.736
Residence county Garissa Ref - -
Wajir 1.09 (0.78–1.51) 0.607
Higher education Yes Ref - Ref -
No 0.39 (0.17–0.81) <0.001 0.71 (0.24–0.96) 0.038
Ethnicity Other Ref - - -
Somali 1.92 (1.29–3.76) 0.004
Zoonosis knowledge No Ref - -
Yes 0.78 (0.36–0.99) 0.025
Occupation Others Ref - - -
Livestock trader 4.09 (1.26–13.27) 0.019
Student 1.05 (0.26–4.14) 0.941
General merchandise 1.06 (0.28–3.96) 0.932
Civil servant 0.81 (0.39–2.76) 0.739
Herder 2.96 (1.15–8.34) 0.041
Animal Contact Cattle
No Ref - Ref -
Yes 2.65 (1.89–3.72) <0.001 2.09 (1.73–5.98) 0.004
Goats
No Ref - Ref -
Yes 4.82 (2.89–8.26) 0.003 3.74 (2.52–9.40) 0.006
Frequent slaughter of animals
No Ref - Ref -
Yes 3.44 (2.46–6.67) <0.001 1.78 (1.09–2.91) 0.021
Contact with birth productsa Ref - - -
1.43 (0.94–2.19) 0.089
Frequent handling of raw milk Ref - - -
1.55 (1.10–2.18) 0.011
Frequently graze animals Ref - - -
1.98 (1.34–2.92) 0.030
Dietary contact Frequent consumption of raw cattle milk
No Ref - Ref -
Yes 6.43 (4.52–9.14) <0.001 2.49 (1.48–4.21) 0.001
Frequent consumption of locally fermented products
No Ref - Ref -
Yes 3.81 (2.73–5.36) <0.001 1.66 (1.19–4.37) 0.014
Frequent consumption of raw goat milk
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first study to evaluate such prediction rule for the diagno-
sis of acute Q fever. Whereas, previous studies designed
to assess clinical and laboratory features of Q fever pa-
tients reported hepatitis and pneumonia as common clin-
ical presentations, the authors did not propose a clinical
prediction rule that could be of value during initial patient
diagnosis [51, 52]. Other studies have assessed the sensi-
tivity and specificity of individual signs and symptoms to
establish clinical diagnosis of febrile etiologies such as ty-
phoid fever [53], malaria [54, 55] and brucellosis relapse
[56] in developing countries. Similar to our study, none of
the constitutional symptoms proved a good predictor of
infection. In our study, the new Q fever score demon-
strated that patients with a score above the cut-off value
of 2.90, were 12 times more likely to test positive for acute
Q fever than those with a score upto the cutoff (OR =
12.7; 95 % CI: 4.89-32.72, P < 0.001).
Within the past decade, malaria has substantially de-
clined in many endemic countries [57]. This together
with the increasing availability and use of malaria rapid
diagnostic tests to exclude malaria have led substantial
adherence to the WHO recommended “test and treat”
policy. However, a growing body of evidence in Africa
shows that clinicians are presently faced with a growing
proportion of patients with severe febrile illness from
previously under-recognized zoonotic diseases but tools
to guide subsequent detection and management are
often lacking [16, 17, 24–27, 40, 43]. Under these cir-
cumstances, the present new Q fever score would be of
particular value to practicing clinicians working in
resource limited countries in making decisions on pa-
tients necessitating meticulous attention in regard to Q
fever during initial diagnosis and empiric treatment. For
instance, using the score supported by screening patients
for the risky epidemiological factors would be useful to
clinicians to make clinical decisions on when to prefer
prescribing doxycycline versus the commonly used peni-
cillin based drugs during empiric treatment of fever of
unknown origin in such underdeveloped areas. However,
we acknowledge that this score may not provide a defini-
tive clinical algorithm for acute Q fever detection be-
cause of the limitations of the present study, but a
clinically supportive guide for clinicians.
We report for the first time the correlates of socio-
economic and dietary practices with Q fever seropositiv-
ity in Kenya. We found higher odds of seropositivity in
individuals who reported regular occupational or domes-
tic contact with goats, cattle and those involved in regu-
lar slaughter of animals, thus highlighting the significant
role of livestock contact in transmission of C. burnetii.
Slaughtering of animals (usually uninspected by health
officials) is a common cultural practice of communities
in the study area e.g. during Eid-al-Adha, dowry pay-
ment, and wedding ceremonies or during the regular
diet preparation [15, 58]. During these events, individ-
uals may be exposed to a high risk of contracting Q
fever. Our results correspond well with previous studies
in different countries that found higher seroprevalences
in persons who were in close contact with cattle and
goats. In addition, consumption of raw cattle milk (aOR:
Table 5 Results of final combined logistic regression analysis showing risk factors found associated with Q fever seropositivity in
febrile patients, northeastern Kenya (Continued)
No Ref - - -
Yes 1.77 (1.20–2.61) 0.004
ALRI
No Ref - Ref -
Yes 3.61 (2.39–5.44) <0.001 2.41 (1.53–6.36) <0.001
Clinical Abdominal pain
No Ref - Ref -
Yes 1.57 (1.01–2.42) 0.004 1.95 (1.08–3.58) 0.019
Diarrhoea
No Ref - Ref -
Yes 0.60 (0.28–1.29) 0.042 0.63 (0.38–1.00) 0.047
Fever onset (>14 days)
No Ref - < 0.001 Ref -
Yes 41.52 (19.78–87.22) 36.35 (19.84–69.49) <0.001
H-L test 0.412
ROC (AUC) 0.718 (0.673–0.784) <0.001
Ref referent category, aOR adjusted odds ratio, CI confidence interval, H-L test Hosmer-Lemeshow goodness- of-fit test, ROC receiver operating characteristics, AUC
area under the curve
aProportion of patients with recent exposure to aborted materials or helped during animal birth
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2.49) and the locally fermented milk products i.e. susac
(aOR: 1.66) were important risk factors. This practice is
also common among the pastoralist communities in the
study area because of strong rooted cultural norms that
associate unboiled milk with high nutrition value [31].
Indeed, most of the patients of Somali ethnic group were
unaware that drinking raw camel or cattle milk was cap-
able of causing diseases and thought that boiling was not
necessary. These practices may present significant risk of
exposure to milk borne pathogens as milk from different
animals is pooled before consumption or fermented into
the traditional products (susac) without a pre-heating
step. Previous epidemiological studies have also de-
scribed strong associations between consumption of raw
milk and C. burnetii seropositivity [52, 59], but the risk
of oral transmission is still widely considered as minimal
compared to aerosol route [60, 61]. Therefore, this evi-
dence can be strengthened by more research to defini-
tively demonstrate the probability of infection through
oral route and determination of pathogens dose capable
of causing the disease.
Limitations
A potential limitation in our findings is that our study was
hospital based where the population under investigation
was febrile patients seeking treatment. Therefore, the
afebrile cases or those that were unable to present to the
hospitals were inevitably not captured by our sampling
strategy. Again, the patient samples were generated in ab-
sence of a robust probabilistic sampling method. This has
the effect of limiting the generalization of the results. A
population-based survey or follow up of patients to obtain
a convalescent sera sample was not feasible due to the no-
madic lifestyle of the patients, the ongoing inter-clans con-
flicts and militia activities in the region. However previous
studies have reported adequate performance of the used
commercial serion ELISA classic test kits in detection of
phase II specific IgG and IgM [36, 62] respectively, in diag-
nosis of acute Q fever. The novelty of the present study was
that the ELISA positive sera were further confirmed with
the reference diagnostic method (IFA) and the patients
whose fever onset was ≤ 2 weeks were further screened for
Q fever using a quantitative real-time PCR. Nevertheless,
the possibility of recent infection cases, false positive or
chronic cases being considered as acute Q fever cannot be
completely rule out.
The utility of our prediction score should be interpreted
in the context of potential limitation. The cross-sectional
nature of the study did not allow more comprehensive
evaluation and follow up of each patient and the fact that
the prediction rule was derived by logistic regression mod-
eling which can be prone to residual confounding effects.
Another potential limitation is related to the heterogeneous
clinical presentation of Q fever in patients and the fact that
the score was validated in patients from the same region
where it was developed. Though deliberate efforts were
made to exclude the commonly reported febrile etiologies
in the region including typhoid fever, malaria and brucel-
losis, unfortunately due to the nature of the present study
and scarcity of appropriate laboratory and radiological sup-
port, a comprehensive differential diagnosis for other febrile
etiologies among our patients was not feasible. These fac-
tors may have affected the discriminatory index of the
present score. Nevertheless, our study was not designed to
give a definite clinical algorithm but one to help clinicians
in distinguishing febrile cases probably due to Q fever from
febrile episodes not due to Q fever and aid in making clin-
ical empiric therapeutic decisions. Therefore, validation of
the present prediction score in well-designed studies in di-
verse independent cohorts is highly warranted.
General recommendations
A one health approach for surveillance of emerging and
remerging infectious diseases should be encouraged in
Kenya to support design and implementation of rational
control strategies for febrile diseases. Education pro-
grammes and appropriate preventive interventions target-
ing the significant risk factors needs to be designed for the
communities at high risk of exposure. Increased clinician
and laboratory personnel awareness and access to labora-
tory testing capacity is needed to enable timely detection
and early treatment to prevent severe sequelae.
Conclusions
This is the first epidemiological study to report Q fever
as a serious public health problem in Northeastern
Kenya and a description of social-cultural, occupa-
tional, and dietary factors influencing human exposure.
We present a simple predictive score based on clinical
features. A Q fever score supported by screening pa-
tients for the risky epidemiological factors will ultim-
ately help clinicians in making clinical judgments in
distinguishing febrile illness probably due to Q fever
from other etiologies and selection of appropriate
therapeutic decisions (e.g. penicillin based antibiotics
versus doxycycline for empiric treatment), particularly
when no microbiological testing is available. The find-
ings also provide a framework to initiate well-designed
research in linked animal and human populations in
different ethnic entities, agricultural production and
management systems in Kenya.
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